版本:
中国

Dialysis chain DaVita wins approval to buy Renal Ventures with conditions

WASHINGTON, March 28 Kidney dialysis company DaVita, Inc has won antitrust approval to buy rival Renal Ventures Management LLC on condition that it sell five clinics, the Federal Trade Commission said on Tuesday.

The clinics to be divested are in New Jersey and Texas, the agency said. (Reporting by Diane Bartz; Editing by Chizu Nomiyama)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐